Latest news
Bacteria frozen in ancient underground ice cave found to be resistant against 10 modern antibiotics
Researchers tested antibiotic resistance profiles of a bacterial strain that until recently was hidden in a 5,000-year-old layer of ice of an underground ice cave – and found it could be an opportunity for developing new strategies to prevent the rise of antibiotic resistance.
A yeast enzyme helps human cells overcome mitochondrial defects
An international team has experimentally uncoupled nucleotide synthesis from mitochondrial activity using ScURA, a yeast-derived genetic tool now available to the research community that will enable new explorations of cellular metabolism.
Rhododendron-derived drugs now made by bacteria
Bioengineered E. coli bacteria can now produce a group of compounds with anticancer, anti-HIV, antidiabetic and anti-inflammatory activities. The compounds, orsellinic acid-derived meroterpenoids, are produced by Rhododendron species.
Scaling up: Fungus plays key role in crafting spalted wood
A new standardized, scalable process deploys a fungal pest of deciduous trees to create a unique woodworking product - spalted wood, with its distinctive etched black markings.
Scientists’ chemical breakthrough sheds light on origins of life
Researchers have discovered a tiny RNA molecule that could explain how life on Earth began. The findings reveal the team has identified a remarkably small ribonucleic acid (RNA) molecule, named QT45, that can copy itself and its complementary strand.
Gut microbiome may be the link to gluten sensitivity without celiac disease
Researchers found that after antibiotic treatment, mice exposed to gluten had changes in the bacteria living in the gut. These shifts in bacteria types altered how they processed carbohydrates, fats and sugars which may influence how these nutrients are recognized by the immune system.
Bacteria frozen in ancient underground ice cave found to be resistant against 10 modern antibiotics
Researchers tested antibiotic resistance profiles of a bacterial strain that until recently was hidden in a 5,000-year-old layer of ice of an underground ice cave – and found it could be an opportunity for developing new strategies to prevent the rise of antibiotic resistance.
Scientists’ chemical breakthrough sheds light on origins of life
Researchers have discovered a tiny RNA molecule that could explain how life on Earth began. The findings reveal the team has identified a remarkably small ribonucleic acid (RNA) molecule, named QT45, that can copy itself and its complementary strand.
Gut microbiome may be the link to gluten sensitivity without celiac disease
Researchers found that after antibiotic treatment, mice exposed to gluten had changes in the bacteria living in the gut. These shifts in bacteria types altered how they processed carbohydrates, fats and sugars which may influence how these nutrients are recognized by the immune system.
Scaling up: Fungus plays key role in crafting spalted wood
A new standardized, scalable process deploys a fungal pest of deciduous trees to create a unique woodworking product - spalted wood, with its distinctive etched black markings.
Valneva provides update on recommendations for use of IXCHIQ® in UK
Valneva SE has announced that following a review of the benefits and risks of the Company’s single-dose chikungunya vaccine, IXCHIQ® , the United Kingdom’s (UK) Commission on Human Medicines (CHM) has updated its recommendations for use of the vaccine.
Technology transfer for Corallopyronin A successfully completed with Phyton Biotech
Phyton Biotech has successfully transferred the manufacturing process for the microbial production of Corallopyronin A (CorA). CorA is a novel anti-infective agent with the potential to address neglected tropical diseases.
A yeast enzyme helps human cells overcome mitochondrial defects
An international team has experimentally uncoupled nucleotide synthesis from mitochondrial activity using ScURA, a yeast-derived genetic tool now available to the research community that will enable new explorations of cellular metabolism.
Rhododendron-derived drugs now made by bacteria
Bioengineered E. coli bacteria can now produce a group of compounds with anticancer, anti-HIV, antidiabetic and anti-inflammatory activities. The compounds, orsellinic acid-derived meroterpenoids, are produced by Rhododendron species.
Immunity against common virus leveraged against pancreatic cancer
Researchers have discovered a promising new treatment approach for pancreatic cancer. The approach leverages the body’s natural immune response to cytomegalovirus (CMV), a common but typically harmless virus that most people are infected with at some point in their lives.
Mpox: recombinant virus with genomic elements of clades Ib and IIb
Recombination of monkeypox virus (MPXV) strains has been documented in recent months, with two cases of a recombinant strain comprising clade Ib and IIb MPXV reported, the World Health Organization says.
Proposals for exploring viruses and skin as the next experimental quantum frontiers share US$30,000 science award
Viruses exist at the boundary between living and non-living matter, while skin is a living interface between physics and biology, making them perfect—but until now overlooked—arenas for testing the interplay between quantum physics, biology and life.
Rapid response launched to tackle new yellow rust strains threatening UK wheat
The UK’s wheat is under threat from a newly identified strain of the yellow rust pathogen, prompting an urgent mobilisation of research institutes to protect harvests. The new strain has overcome a key resistance gene that was protecting many major UK wheat varieties from yellow rust infection.